Volver a Agenda
Mergers & Acquisitions – The Multinational Pharma Quagmire
Session Chair(s)
Moin Don
Adjunct Professor, Jamia Hamdard University, Dept of Pharmacology, School of
Pharmacy, Lead : South Asia Chapter – ISoP, Founder & CEO, PV Consulting, India
Mergers & Acquisitions (M&A) within pharma companies has become a regular phenomenon and needs deeper analysis to understand its dynamics. During M&A, it is not only the PV domain which needs critical attention from a management perspective but equally important are others functions such as Legal/Regulatory Affairs/ Safety Database/ Change in QPPV &PSMF, etc. This session shall explore encompassing all such challenges faced by pharma companies during M&A process.
Speaker(s)
Contributing Panelist
Seema Jaitly, DrMed
Essjay Solutions Ltd, United Kingdom
Managing Director
Contributing Panelist
Manish Paliwal
Pfizer, Inc., India
Director, Regulatory Affairs
Contributing Panelist
Preeti Verma
Qinecsa Solutions , United States
Senior Director, Solution Architect Leader, Business Development,
![Gaurav Shah](/_Images/member/Generic_Image_Missing-Profile.jpg)
Contributing Panelist
Gaurav Shah
Viatris Laboratories Ltd, India
Deputy General Manager, Product Safety and Risk Management
Contributing Panelist
Gaurang Shah
GAURANG SHAH & ASSOCIATES, India
Proprietor
¿Tiene una cuenta?